Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Human Cancer Biology

Differentially Regulated Micro-RNAs and Actively Translated Messenger RNA Transcripts by Tumor Suppressor p53 in Colon Cancer

Yaguang Xi, Reut Shalgi, Oystein Fodstad, Yitzhak Pilpel and Jingfang Ju
Yaguang Xi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reut Shalgi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oystein Fodstad
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yitzhak Pilpel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jingfang Ju
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-05-1853 Published April 2006
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Hierarchical clustering analysis of miRNA expression (light gray, overexpressed genes; dark gray underexpressed genes). miRNAs were isolated from actively translated RNA population in HCT-116 (wt-p53) and HCT-116 (null-p53) cells using gel fractionation. The level of miRNAs were quantified with miRNA array analysis. The expression of miRNAs were analyzed using Feature Extraction Software. The signal of each probe was set as its median intensity. The threshold for reliable probe signals was set at 1,500. Clustering analysis was done using CLUSTER 3.0/TreeView software (23).

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    A, effect of p53 siRNA knockdown on the expression of wt-p53 via Western immunoblot analysis. HCT-116 (wt-p53) cells were transfected with siRNA mismatch control and wt-p53-specific siRNA and the expression levels of wt-p53 were quantified via Western immunoblot analysis [lane 1, control; lane 2, mismatch control; lane 3, Lamin A/C positive control; lane 4, 100 nmol/L siRNA; lane 5, 400 nmol/L siRNA; lane 6, HCT-116 (null-p53)]. B, real-time qRT-PCR analysis of has-miR-26a expression [n = 3; lane 1, control; lane 2, mismatch control; lane 3, Lamin A/C positive control; lane 4, 100 nmol/L siRNA; lane 5, 400 nmol/L siRNA; lane 6, HCT-116 (null-p53)]. 5S rRNA was used as internal standard for expression normalization.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    A, hierarchical clustering analysis of steady-state total mRNAs expression profile between HCT-116 (wt-p53; lane 1) and HCT-116 (null-p53; lane 2) cells via microarray expression analysis (red, overexpressed genes; blue, underexpressed genes). B, hierarchical clustering analysis of actively translated mRNAs expression profile between HCT-116 (wt-p53; lane 1) and HCT-116 (null-p53; lane 2) cells (red, overexpressed genes; blue, underexpressed genes).

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    miRNA target prediction for hsa-miR-15b, hsa-miR-125a, hsa-miR-128b, and hsa-miR-10a. Potential mRNA targets with several miRNAs using predictive software (miRNada; refs. 28, 36).

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    A, effect of 5-FU treatment on the expression of p53 via Western immunoblot analysis [lane 1, control HCT-116 (wt-p53); lane 2, HCT-116 (wt-p53) cells treated with 10 μmol/L 5-FU for 24 hours; lane 3, control HCT-116 (null-p53); lane 4, HCT-116 (null-p53) cells treated with 10 μmol/L 5-FU for 24 hours]. B, expression of wt-p53 mRNA from HCT-116 (wt-p53) control cells and cells treated with 10 μmol/L 5-FU for 24 hours analyzed by real-time qRT-PCR analysis (n = 3). The expression of housekeeping gene GAPDH was used as internal control. C, effect of 5-FU treatment on hsa-miR-26a expression analyzed by real-time miRNA qRT-PCR (n = 3) and 5S rRNA was used as internal standard. The ratio of target miRNA and 5S rRNA was used to calculate the relative expression.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Schematic illustration of p53 regulatory pathways. Wt-p53 not only acts as a typical transcription factor to regulate a number of cellular mRNAs at the transcriptional level, but also regulates gene expression at posttranscriptional and translational events via its RNA-binding function. In addition, wt-p53 regulates a number of noncoding miRNAs at the transcriptional level thereby influences certain cellular mRNAs translation through its mediated miRNAs. Wt-p53 also influences apoptosis pathway via accumulation to the mitochondria.

Tables

  • Figures
  • Table 1.

    Expression analysis of miRNAs using MIRCHIP2 array in HCT-116 (wt-p53) and HCT-116 (null-p53) cells

    Up-regulated miRNAFold-changeDown-regulated miRNAFold change
    Hsa-miR-30a-5p+32.56Hsa-miR-15b−126.34
    Hsa-miR-181b+11.87Hsa-miR-27a−60.76
    Hsa-miR-372+6.57Hsa-miR-200c−58.30
    Hsa-let-7g+4.93Hsa-miR-191−56.39
    Hsa-miR-26a+2.27Hsa-miR-30c−50.12
    Hsa-let-7b+2.26Hsa-miR-25−49.24
    Hsa-miR-296+2.26Hsa-miR-107−48.55
    Hsa-miR-30a-3p+2.00Hsa-miR-339−46.52
    Hsa-miR-21+1.89Hsa-miR-125a−39.97
    Hsa-miR-132+1.58Hsa-miR-27b−32.84
    Hsa-miR-181a+1.34Hsa-miR-23a−28.88
    Hsa-miR-320+1.05Hsa-miR-10a−3.51
  • Table 2.

    Prediction of putative p53-binding sites of miRNA promoters

    miRNASite position (upstream miRNA)GapSequenceSite score
    Shorter gap sites
        Hsa-let-7b8280AGCCATGTCT…CTTCTTGTCT87.56
        Hsa-mir-26a-13,1082CAGCAAGACT…GGGCAAGAGC86.96
        Hsa-mir-26a-23,0240GCCCTTGCCC…CTGCTTGTCT86.30
        Hsa-mir-3723,6613CGCCATGTTG…AGGCTAGTCT84.81
        Hsa-let-7b3,6281TCGCATGCCT…TGTCTTGCTG83.73
        Hsa-mir-181b-11,4200AGCCAAGCTT…TGGCATGACT82.44
        Hsa-mir-200c2,1832AGACAAGGAG…GAGCAAGGGT81.59
        Hsa-mir-26a-21743CAGCATGTTG…AGTCAAGTTC80.06
    Longer gap sites
        Hsa-mir-200c3,80711ATACAAGCCG…AGGCAAGTCC89.80
        Hsa-mir-181b-11,4707AAACATGTCC…CAACTTGCCT89.00
        Hsa-mir-181b-14,5946GAACTAGCCC…GGCCATGTTT88.70
        Hsa-mir-26a-24,84013AAGCAAGCAC…GAGCAAGACT87.77
        Hsa-let-7g1,62011AGGCTTGCCT…CAGCAAGCGC86.69
        Hsa-mir-26a-24,06612CAGCTTGCTT…TGCCATGCCC85.20
        Hsa-mir-26a-24,0708TTGCTTGCCC…TGCCATGCCC84.06
        Hsa-mir-26a-14,4966ACGCAAGTCC…TCCCATGTCC83.60
        Hsa-mir-26a-14,49612ACGCAAGTCC…GTCCTTGCTT83.29
        Hsa-mir-26a-24,8467GCACAAGATC…GAGCAAGACT83.12
        Hsa-mir-27a2,06011CCTCATGCCT…GAGCTTGGTT81.88
        Hsa-let-7b2,62410GGGCATGGGG…TAGCATGCCG80.81
        Hsa-mir-26a-24,86312GAGCAAGACT…TGTCTAGTCT80.66
        Hsa-mir-26a-11,4379TGCCTTGTTC…GGGCATGCAG80.52
        Hsa-mir-26a-14,5124TCCCATGTCC…TTTCTTGCTT80.33
        Hsa-mir-181b-21,3306AAACATGAAT…TGACATGCTG80.28
  • Table 3.

    Expression analysis of steady-state total mRNA transcripts in HCT-116 (wt-p53) and HCT-116 (null-p53) cells

    Genbank accession no.Gene IDFold changeBiological function
    Increased genes
        NM_000474TWIST+34.30Cell differentiation; chromosome organization and biogenesis
        NM_001225CASP4+20.22Apoptosis; proteolysis and peptidolysis
        NM_012427KLK5+11.13Epidermis development; proteolysis and peptidolysis
        NM_004172SLC1A3+11.07l-Glutamate transport; dicarboxylic acid transport
        NM_005930MGEA6+10.92RNA processing
        D16350SAH+10.07Metabolism; regulation of blood pressure
        NM_004864PLAB+9.75Cell-cell signaling; signal transduction
        NM_025048FLJ22684+9.46Neuropeptide signaling pathway
        AB029015PLCL2+9.11Intracellular signaling cascade; lipid metabolism
        NM_016135TEL2+9.00Organogenesis; regulation of transcription
        NM_006017PROML1+8.88Visual perception
        NM_002923RGS2+8.54Cell cycle; G-protein signaling pathway; signal transduction
        M23419EIF5A;TNNI3+7.09Protein biosynthesis; translational initiation
        NM_003633ENC1+6.99Development; neurogenesis
        AK023349Nup43+4.97Intracellular protein transport
        NM_005596NFIB+4.89DNA replication; regulation of transcription, DNA dependent
        NM_012198GCA+3.96Membrane fusion
        NM_001654ARAF1+3.92Cell growth and/or maintenance; intracellular signaling cascade
        NM_001387DPYSL3+3.88Neurogenesis; signal transduction
        NM_000043TNFRSF6+3.80Apoptosis; immune response; protein assembly; signal transduction
        NM_000389CDKN1A+3.55Cell cycle; apoptosis; cell proliferation; regulation of CDK activity
        BC007613CRMP1+3.14Neurogenesis; nucleobase, nucleoside, nucleotide and nucleic acid metabolism
        AK057343ZNF131+3.11Regulation of transcription, DNA-dependent
        NM_052966C1orf24+3.08Protein folding
    Decreased genes
        NM_014178HSPC156−21.83Vesicle-mediated transport
        NM_000582SPP1−19.53T-helper 1 type immune response; antiapoptosis; cell-cell signaling
        NM_001147ANGPT2−13.04Angiogenesis; cell growth and/or maintenance; signal transduction
        NM_003121SPIB−11.76Regulation of transcription from Pol II promoter
        BC010398PMPCB−7.41Proteolysis and peptidolysis
        NM_000310PPT1−5.26Neurogenesis; protein modification; visual perception
        NM_000465BARD1−4.59Protein ubiquitination
        NM_016611KCNK4−4.29Ion transport; potassium ion transport
        NM_001901CTGF−3.50DNA metabolism; cell adhesion; cell growth; cell motility
        NM_003925MBD4−3.34Base-excision repair
        NM_005627SGK−3.09Apoptosis; phosphorylation; response to stress; sodium ion transport
        NM_005834TIMM17B−3.06Protein-mitochondrial targeting
        NM_013961NRG1−3.06Cell differentiation; embryonic development; neurogenesis
  • Table 4.

    Expression analysis of actively translated mRNA transcripts in HCT-116 (wt-p53) and HCT-116 (null-p53) cells

    Genbank accession no.Gene IDFold changeBiological function
    Increased genes
        NM_016292TRAP1+19.01Protein folding
        NM_014474ASML3B+13.51Carbohydrate metabolism
        NM_001654ARAF1+12.79Cell growth and/or maintenance; intracellular signaling cascade
        NM_000178GSS+11.20Amino acid metabolism; glutathione biosynthesis; neurogenesis
        NM_001225CASP4+8.83Apoptosis; proteolysis and peptidolysis
        NM_001402EEF1A1+8.44Protein biosynthesis; regulation of translation
        NM_000918P4HB+7.86Electron transport
        NM_004335BST2+7.28Cell proliferation; cell-cell signaling; development; immune response
        NM_006743RBM3+6.85RNA processing
        NM_004046ATP5A1+6.83ATP synthesis–coupled proton transport
        NM_000546TP53+6.58Apoptosis; DNA recombination; DNA repair; cell cycle; transcription
        NM_004317ASNA1+6.54Anion transport; response to arsenate
        NM_004127GPS1+6.19c-Jun-NH2-kinase cascade; cell cycle; inactivation of mitogen-activated protein kinase
        NM_000291PGK1+6.13Glycolysis
        NM_003752EIF3S8+6.12Protein biosynthesis; regulation of translational initiation
        NM_005500SAE1+5.85Protein ubiquitination
        NM_000107DDB2+5.70Nucleotide-excision repair
        AK024835CNN2+5.68Cytoskeleton organization; smooth muscle contraction
        NM_003915CPNE1+5.62Lipid metabolism; vesicle-mediated transport
        NM_006374STK25+5.53Phosphorylation; response to oxidative stress; signal transduction
        NM_017916FLJ20643+5.44Metabolism
        NM_006400DCTN2+5.35Cell proliferation; microtubule-based process; mitosis
        NM_000474TWIST+5.19Cell differentiation; chromosome organization and biogenesis
        NM_005030PLK+5.09Mitosis; protein amino acid phosphorylation; regulation of cell cycle
        BC033103INPP5E+5.04Proteolysis and peptidolysis
        NM_032272MAF1+4.91Regulation of transcription, DNA-dependent
        NM_001970EIF5A+4.85Protein biosynthesis; translational initiation
        NM_006201PCTK1+4.73Protein amino acid phosphorylation; regulation of cell cycle
        NM_005654NR2F1+4.66Regulation of transcription, DNA-dependent; signal transduction
        NM_003633ENC1+4.62Development; neurogenesis
        NM_016016CGI-69+4.60Transport
        NM_000967RPL3+4.58Protein biosynthesis
        NM_016645NEUGRIN+4.56Neuron differentiation
        NM_018658KCNJ16+4.38Ion transport; potassium ion transport
        NM_004864PLAB+4.33Cell-cell signaling; signal transduction
        NM_003624RANBP3+4.29Small GTPase-mediated signal transduction
        NM_004559NSEP1+4.28Regulation of transcription; response to pest/pathogen/parasite
        NM_012427KLK5+4.14Epidermis development; proteolysis and peptidolysis
        NM_001085SERPINA3+4.12Inflammatory response; regulation of lipid metabolism
        NM_021734SLC25A19+4.12Deoxynucleotide transport
        NM_000175GPI+4.10Carbohydrate metabolism; gluconeogenesis; glycolysis; hemostasis
        NM_001908CTSB+4.10Proteolysis and peptidolysis
        NM_002923RGS2+4.01Cell cycle; G-protein signaling pathway; signal transduction
        NM_000687AHCY+3.95One-carbon compound metabolism
        NM_000190HMBS+3.94Heme biosynthesis
        NM_013388PREB+3.93Regulation of transcription, DNA dependent
        NM_005410SEPP1+3.92Response to oxidative stress
        NM_015679CLONE24922+3.87RNA processing
        NM_021008DEAF1+3.82Regulation of transcription, DNA dependent
        AK000822DKFZP564M182+3.75Protein biosynthesis
        NM_000182HADHA+3.74Fatty acid metabolism
        NM_002611PDK2+3.70Glucose metabolism; signal transduction
        NM_005802TP53BPL+3.68Protein ubiquitination
        AF016266TNFRSF10B+3.59Caspase activation; electron transport; induction of apoptosis
        NM_001536HRMT1L2+3.58Signal transduction; defense response; methylation
        NM_133455LOC129080+3.52Phosphate transport
        NM_001640APEH+3.51Proteolysis and peptidolysis
        NM_001416EIF4A1+3.50Protein biosynthesis
        NM_006388HTATIP+3.33Regulation of transcription, DNA-dependent; transcription
        NM_006112PPIE+3.29Protein folding
        NM_000308PPGB+3.28Intracellular protein transport; proteolysis and peptidolysis
        NM_002046GAPD+3.24Glucose metabolism; glycolysis
        NM_001130AES+3.24Wnt receptor signaling pathway; development; transcription
    Decreased genes
        NM_014178HSPC156−27.25Vesicle-mediated transport
        NM_006533MIA−15.34Cell proliferation
        NM_006993NPM3−7.58Protein folding
        NM_005554KRT6A−6.62Ectoderm development
        NM_002274KRT13−5.75Epidermis development
        NM_003125SPRR1B−4.81Epidermis development
        NM_000117EMD−4.76Muscle contraction; muscle development
        NM_006072SCYA26−4.69Cell-cell signaling; immune response; signal transduction
        BC014000LOC115509−4.18Regulation of transcription, DNA dependent
        NM_024710FLJ23469−3.88Metabolism
        NM_002906RDX−3.47Cytoskeletal anchoring
PreviousNext
Back to top
Clinical Cancer Research: 12 (7)
April 2006
Volume 12, Issue 7
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Differentially Regulated Micro-RNAs and Actively Translated Messenger RNA Transcripts by Tumor Suppressor p53 in Colon Cancer
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Differentially Regulated Micro-RNAs and Actively Translated Messenger RNA Transcripts by Tumor Suppressor p53 in Colon Cancer
Yaguang Xi, Reut Shalgi, Oystein Fodstad, Yitzhak Pilpel and Jingfang Ju
Clin Cancer Res April 1 2006 (12) (7) 2014-2024; DOI: 10.1158/1078-0432.CCR-05-1853

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Differentially Regulated Micro-RNAs and Actively Translated Messenger RNA Transcripts by Tumor Suppressor p53 in Colon Cancer
Yaguang Xi, Reut Shalgi, Oystein Fodstad, Yitzhak Pilpel and Jingfang Ju
Clin Cancer Res April 1 2006 (12) (7) 2014-2024; DOI: 10.1158/1078-0432.CCR-05-1853
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Contact Guidance Controls T-cell Migration in PDAC
  • MET in Papillary RCC
  • Identification of T-cell Antigens by Minigene Screening
Show more Human Cancer Biology
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement